-
Halozyme Therapeutics (NASDAQ:HALO) Price Target Cut to $57.00 by Analysts at Wells Fargo & Company
Source: Buzz FX / 13 Jan 2025 10:56:16 America/New_York
Halozyme Therapeutics (NASDAQ:HALO) Price Target Cut to $57.00 by Analysts at Wells Fargo & Company Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Halozyme Therapeutics ( NASDAQ:HALO - Get Free Report ) had its targe
Read more...